Malignancy Risk Assessment, Pelvic Mass, OVA1 Plus
Test Mnemonic
OVA1
CPT Codes
- 81503 - QTY (1)
Includes
- EER Malignancy Assessment, OVA1 Plus
- Malignancy Assessment, Menopausal Status
- Malignancy Assessment, CA 125 II
- Malignancy Assessment, OVA1 Score
- Malignancy Assessment, OVERA Score
Performing Laboratory
ARUP
Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 2.2 mL | Serum | SST (Gold) | Frozen | Menopausal Status required at time of ordering. Separate serum from cells and transfer to standard aliquot tube. |
Minimum Specimen Requirements
| Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
|---|---|---|---|---|---|
| 1.1 mL |
Stability
| Environmental Condition | Description |
|---|---|
| Ambient | Unacceptable |
| Refrigerated | 8 days |
| Frozen | 9 weeks |
Days Performed
Varies
Turnaround Time
5 - 9 days
Methodology
| Name | Description |
|---|---|
| Electro Chemiluminescence Immunoassay (ECLIA) | |
| Fixed Rate Time Nephelometry |
Reference Range
Special Info
Menopausal Status required at time of ordering. This test is New York state approved.
Clinical Info
This test is useful to assess risk of ovarian cancer in women who present with an adnexal mass. OVA1 Biomarkers: CA-125 II, Apoliproprotein A1 (Apo A-1), Beta-2 Microglobulin (B2M), Transferrin, and Prealbumin. OVERA Biomarkers: Apolipoprotein A1 (Apo A-1), HE4 (Human Epididymis protein 4), CA-125 II, FSH (Follicle Stimulating Hormone), and Transferrin.